O-015Randomised trial of cetuximab every 2 weeks with FOLFIRI or cetuximab with alternating FOLFIRI/FOLFOX in patients with RAS and BRAF wild type metastatic colorectal cancer: Nordic 8 results. (2nd July 2019) - Pfeiffer, P; Glimelius, B; Winther, S; Qvortrup, C; Yilmaz, M; Berglund, À; Vistisen, K; Kersten, C; Liposits, G; Sorbye, H